دورية أكاديمية
أعرض في EDS

Umbilical Cord Mesenchymal Stromal Cells for Steroid-Refractory Acute Graft-versus-Host Disease.

التفاصيل البيبلوغرافية
العنوان: Umbilical Cord Mesenchymal Stromal Cells for Steroid-Refractory Acute Graft-versus-Host Disease.
المؤلفون: Donadel CD; Regional Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 05508-220, Brazil., Pires BG; Department of Medical Imaging, Hematology and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 05508-220, Brazil., André NC; Regional Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 05508-220, Brazil., Costa TCM; Department of Medical Imaging, Hematology and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 05508-220, Brazil., Orellana MD; Regional Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 05508-220, Brazil., Caruso SR; Regional Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 05508-220, Brazil., Seber A; Grupo de Apoio ao Adolescente e à Criança com Câncer (GRAACC), Universidade Federal de São Paulo (UNIFESP), São Paulo 04021-001, Brazil.; Hospital Samaritano, São Paulo 01232-010, Brazil., Ginani VC; Grupo de Apoio ao Adolescente e à Criança com Câncer (GRAACC), Universidade Federal de São Paulo (UNIFESP), São Paulo 04021-001, Brazil.; Hospital Samaritano, São Paulo 01232-010, Brazil., Gomes AA; Hospital Sírio Libanês, São Paulo 01308-050, Brazil., Novis Y; Hospital Sírio Libanês, São Paulo 01308-050, Brazil., Barros GMN; Barretos Cancer Hospital, Barretos 14784-400, Brazil., Vilella NC; Barretos Cancer Hospital, Barretos 14784-400, Brazil., Martinho GH; Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Brazil., Vieira AK; Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Brazil., Kondo AT; Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil., Hamerschlak N; Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil., Filho JS; Hospital A.C.Camargo Cancer Center, São Paulo 01525-001, Brazil., Xavier EM; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo 05403-010, Brazil., Fernandes JF; Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.; Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 01246-903, Brazil., Rocha V; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo 05403-010, Brazil., Covas DT; Regional Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 05508-220, Brazil.; Department of Medical Imaging, Hematology and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 05508-220, Brazil., Calado RT; Regional Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 05508-220, Brazil.; Department of Medical Imaging, Hematology and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 05508-220, Brazil., Guerino-Cunha RL; Department of Medical Imaging, Hematology and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 05508-220, Brazil., De Santis GC; Regional Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 05508-220, Brazil.; Department of Medical Imaging, Hematology and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 05508-220, Brazil.
المصدر: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Mar 30; Vol. 16 (4). Date of Electronic Publication: 2023 Mar 30.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, c2004-
مستخلص: Background: Steroid-refractory acute graft-vs.-host disease (SR-aGVHD) is a complication of allogeneic hematopoietic stem cell transplantation with a dismal prognosis and for which there is no consensus-based second-line therapy. Ruxolitinib is not easily accessible in many countries. A possible therapy is the administration of mesenchymal stromal cells (MSCs).
Methods: In this retrospective study, 52 patients with severe SR-aGVHD were treated with MSCs from umbilical cord (UC-MSCs) in nine institutions.
Results: The median (range) age was 12.5 (0.3-65) years and the mean ± SD dose (×10 6 /kg) was 4.73 ± 1.3 per infusion (median of four infusions). Overall (OR) and complete response (CR) rates on day 28 were 63.5% and 36.6%, respectively. Children ( n = 35) had better OR (71.5% vs. 47.1%, p = 0.12), CR (48.6% vs. 11.8%, p = 0.03), overall survival ( p = 0.0006), and relapse-free survival ( p = 0.0014) than adults ( n = 17). Acute adverse events (all of them mild or moderate) were detected in 32.7% of patients, with no significant difference in children and adult groups ( p = 1.0).
Conclusions: UC-MSCs are a feasible alternative therapy for SR-aGVHD, especially in children. The safety profile is favorable.
References: Front Immunol. 2020 Jun 25;11:1338. (PMID: 32670295)
Bone Marrow Transplant. 1995 May;15(5):663-8. (PMID: 7670393)
Cochrane Database Syst Rev. 2014 Apr 20;(4):CD010189. (PMID: 24748537)
Biol Blood Marrow Transplant. 2012 Aug;18(8):1150-63. (PMID: 22510384)
Blood. 2020 May 14;135(20):1739-1749. (PMID: 32160294)
Lancet. 2004 May 1;363(9419):1439-41. (PMID: 15121408)
Cytometry A. 2018 Jan;93(1):19-31. (PMID: 29072818)
Biol Blood Marrow Transplant. 2009 Dec;15(12):1628-33. (PMID: 19896087)
Hum Immunol. 1990 Oct;29(2):79-91. (PMID: 2249952)
Front Immunol. 2021 Oct 26;12:761616. (PMID: 34764962)
PLoS One. 2012;7(10):e47559. (PMID: 23133515)
Biol Blood Marrow Transplant. 2014 Jun;20(6):872-80. (PMID: 24631738)
Br J Haematol. 1990 Apr;74(4):492-6. (PMID: 2346728)
Cochrane Database Syst Rev. 2019 Jan 30;1:CD009768. (PMID: 30697701)
Biol Blood Marrow Transplant. 2020 May;26(5):855-864. (PMID: 32044400)
Front Immunol. 2022 Mar 18;13:839844. (PMID: 35371003)
Acta Oncol. 2020 Jul;59(7):789-792. (PMID: 32079438)
N Engl J Med. 2017 Nov 30;377(22):2167-2179. (PMID: 29171820)
Blood. 2007 Dec 15;110(13):4576-83. (PMID: 17785583)
Lancet. 2009 May 2;373(9674):1550-61. (PMID: 19282026)
Biol Blood Marrow Transplant. 2016 Jan;22(1):4-10. (PMID: 26386318)
Stem Cell Res Ther. 2021 Mar 18;12(1):192. (PMID: 33736695)
Bone Marrow Transplant. 2018 Nov;53(11):1401-1415. (PMID: 29872128)
N Engl J Med. 2020 May 7;382(19):1800-1810. (PMID: 32320566)
J Exp Pharmacol. 2020 Nov 26;12:549-557. (PMID: 33273867)
EClinicalMedicine. 2020 Jan 17;19:100249. (PMID: 31989101)
Adv Hematol. 2011;2011:601953. (PMID: 22110505)
Br J Haematol. 2019 Aug;186(3):e47-e50. (PMID: 30919931)
Stem Cells Int. 2018 Apr 11;2018:4083921. (PMID: 30057622)
Biol Blood Marrow Transplant. 2020 May;26(5):835-844. (PMID: 31505228)
Bone Marrow Transplant. 2021 Oct;56(10):2355-2366. (PMID: 33976381)
Clin Exp Med. 2023 Jan 4;:. (PMID: 36598673)
Biol Blood Marrow Transplant. 2020 May;26(5):845-854. (PMID: 32018062)
Lancet. 2008 May 10;371(9624):1579-86. (PMID: 18468541)
Blood Adv. 2020 Nov 24;4(22):5877-5887. (PMID: 33232479)
Clin Infect Dis. 2017 Nov 13;65(11):1884-1896. (PMID: 29020286)
Bone Marrow Transplant. 2017 Jun;52(6):859-862. (PMID: 28287644)
Biol Blood Marrow Transplant. 2015 Feb;21(2):266-74. (PMID: 25445023)
Clin Trials. 2017 Jun;14(3):255-263. (PMID: 28545337)
Lancet Haematol. 2020 Feb;7(2):e157-e167. (PMID: 32004485)
Haematologica. 2016 Aug;101(8):985-94. (PMID: 27175026)
Bone Marrow Transplant. 2009 Oct;44(8):471-82. (PMID: 19861981)
J Clin Oncol. 2008 Dec 10;26(35):5728-34. (PMID: 18981462)
Biol Blood Marrow Transplant. 2015 Apr;21(4):761-7. (PMID: 25585275)
Front Immunol. 2020 Oct 19;11:567210. (PMID: 33193339)
معلومات مُعتمدة: 2013/08135-2 São Paulo Research Foundation
فهرسة مساهمة: Keywords: acute graft-versus-host disease; hematopoietic stem cell transplantation; mesenchymal stromal cell
تواريخ الأحداث: Date Created: 20230428 Latest Revision: 20230501
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10144752
DOI: 10.3390/ph16040512
PMID: 37111270
قاعدة البيانات: MEDLINE
الوصف
تدمد:1424-8247
DOI:10.3390/ph16040512